Evita Weagel holds a PhD in microbiology and molecular biology with focus on cancer immunology, and is developing immunotherapies targeting cancer.
Intro paths
YC
Evita went through Y Combinator (Winter 2024) — any YC alum in your network can reach them through the YC community.
→
In turn, Evita can intro founders to Eris Biotech's investors below.
Eris Biotech's investors · 1
Co-founders
Rachel Garlick· Founder